- Home
- SIEB vs ARMP Comparison
SIEB vs ARMP Comparison
Compare SIEB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- ARMP
- Stock Information
- Founded
- SIEB 1886
- ARMP N/A
- Country
- SIEB United States
- ARMP United States
- Employees
- SIEB N/A
- ARMP N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIEB Finance
- ARMP Health Care
- Exchange
- SIEB Nasdaq
- ARMP Nasdaq
- Market Cap
- SIEB 110.4M
- ARMP 104.3M
- IPO Year
- SIEB N/A
- ARMP N/A
- Fundamental
- Price
- SIEB $2.93
- ARMP $3.12
- Analyst Decision
- SIEB
- ARMP Strong Buy
- Analyst Count
- SIEB 0
- ARMP 1
- Target Price
- SIEB N/A
- ARMP $9.00
- AVG Volume (30 Days)
- SIEB 46.0K
- ARMP 7.8K
- Earning Date
- SIEB 11-11-2025
- ARMP 11-12-2025
- Dividend Yield
- SIEB N/A
- ARMP N/A
- EPS Growth
- SIEB N/A
- ARMP N/A
- EPS
- SIEB 0.24
- ARMP N/A
- Revenue
- SIEB $86,037,000.00
- ARMP $6,868,000.00
- Revenue This Year
- SIEB N/A
- ARMP $8.43
- Revenue Next Year
- SIEB N/A
- ARMP N/A
- P/E Ratio
- SIEB $12.39
- ARMP N/A
- Revenue Growth
- SIEB 9.07
- ARMP 84.67
- 52 Week Low
- SIEB $2.08
- ARMP $0.90
- 52 Week High
- SIEB $5.77
- ARMP $3.14
- Technical
- Relative Strength Index (RSI)
- SIEB 47.80
- ARMP 62.83
- Support Level
- SIEB $2.82
- ARMP $2.94
- Resistance Level
- SIEB $2.97
- ARMP $3.07
- Average True Range (ATR)
- SIEB 0.13
- ARMP 0.08
- MACD
- SIEB 0.03
- ARMP -0.01
- Stochastic Oscillator
- SIEB 29.55
- ARMP 97.96
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.